Asahi Kasei Medical
  • Site Map
  • Contact Us
  • Font size: Small
  • Font size: Medium
  • Font size: Large
  • Home
  • Our Approach to Business
  • Corporate Information
  • News
  • Products
  • Patients and Families

Leukocytapheresis(LCAP)

References

Reference literature for LCAP methods.

Featured references

Shibata et al.
Cellsorba.
Therap Apher Dial. 7:44-7, 2003.
Matsumoto et al.
Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study.
Ther Apher Dial. 12:484-90, 2008.

All references

Nagase et al.
Complications of Leukocytapheresis.
Ther Apher. 2:120-4, 1998.
Kosaka et al.
Effect of leukocytapheresis therapy using a leukocyte removal filter in Crohn's disease.
Intern Med. 38:102-11, 1999.
Hidaka et al.
Dynamic changes in cytokine levels in serum and synovial fluid following filtration leukocytapheresis therapy in patients with rheumatoid arthritis.
J Clin Apheresis. 16:74-81, 2001.
Yamaji et al.
Fluctuations in the peripheral blood leukocyte and platelet counts in leukocytapheresis in healthy volunteers.
Ther Apher. 6:402-12, 2002.
Shibata et al.
Cellsorba.
Therap Apher Dial. 7:44-7, 2003.
Sawada et al.
Multicenter randomized controlled trial for the treatment of ulcerative colitis with a leukocytapheresis column.
Current Pharmaceutical Design 9:307-21, 2003.
Fukunaga et al.
Poorly controlled ulcerative colitis treated by colectomy during remission induced by extracorporeal leukocyte removal therapy.
J Gastroenterol. 38:684-9, 2003.
Kohgo et al.
Leukocytapheresis for treatment of IBD.
J Gastroenterol. 38 Suppl 15:51-4, 2003.
Sawada K.
Leukocytapheresis as an adjunct to conventional medication for inflammatory bowel disease.
Dis Colon Rectum. 46 Suppl: S66-77, 2003.
Andoh et al.
Suppression of interleukin-1beta- and tumor necrosis factor-alpha-induced inflammatory responses by leukocytapheresis therapy in patients with ulcerative colitis.
J Gastroenterol. 39:1150-7, 2004.
Sawada et al.
Leukocytapheresis in ulcerative colitis: results of a multicenter double-blind prospective case-control study with sham apheresis as placebo treatment.
Am J Gastroenterol. 100:1362-9, 2005.
Sawada et al.
Leukocytapheresis (LCAP) for management of fulminant ulcerative colitis with toxic megacolon.
Dig Dis Sci. 50:767-73, 2005.
Ashizuka et al.
Leukocytapheresis for ulcerative colitis: a comparative study of anticoagulant (nafamostat mesilate vs. dalteparin sodium) for reducing clinical complications.
Ther Apher Dial. 10:54-8, 2006.
Sandborn WJ.
Preliminary data on the use of apheresis in inflammatory bowel disease.
Inflamm Bowel Dis. 12 Suppl 1:S15-21, 2006.
Matsumoto et al.
Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study.
Ther Apher Dial. 12:484-90, 2008.
Mitsuyama et al.
Mobilization of bone marrow cells by leukocytapheresis in patients with ulcerative colitis.
Ther Apher Dial. 12:271-7, 2008.
Mitsuyama et al.
Therapeutic leukocytapheresis in inflammatory bowel disease: clinical efficacy and mechanisms of action.
Cytotherapy. 11:229-37, 2009.
Muratov et al.
Safety and tolerability of a modified filter-type device for leukocytapheresis using ACD-A as anticoagulant in patients with mild to moderately active ulcerative colitis. Results of a pilot study.
J Clin Apher. 25:287-93, 2010.
Ashida et al.
A multicenter study of the efficacy and safety of leukocytapheresis therapy without concomitant systemic steroid treatment in patients with active ulcerative colitis.
Transfus Apher Sci. 44:113-7, 2011.
Fukunaga et al.
Optimal apheresis treatment volume for the efficacy and safety of leukocytapheresis with Cellsorba in patients with active ulcerative colitis.
J Clin Apher. 26:326-31, 2011.
Okuyama et al.
Multicenter prospective study for clinical and endoscopic efficacies of leukocytapheresis therapy in patients with ulcerative colitis.
Scand J Gastroenterol. 48:412-8, 2013.

Contact Us

Please feel free to send us any questions you may have about our products and support.

Contact Us

Your Voice

Share your feelings and experiences when using our products.

Your Voice
Note: It might be required in your country that medical devices shall be officially registered and/or approved by an authorized organization. Please contact our representative in your region or contact us to confirm whether the listed products are approved for use. These information may contain general information on medical-related topics and is not meant to provide specialist advice or instructions concerning the products and services sold by Asahi Kasei Medical. Please contact us directly for special inquiries. You should not use this information for diagnosing a health problem or disease but should always consult your own physician.Contact us

Top of page